NCT07093749 Perspectives on Antibiotics and Tracking Symptoms in Children
| NCT ID | NCT07093749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Murdoch Childrens Research Institute |
| Condition | Urinary Tract Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-09-16 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-09-16 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who present with uncomplicated bacterial infections at the Royal Children's Hospital (RCH) Emergency Department (ED). The study will involve (i) children discharged from ED on oral antibiotics and (ii) children transferred to Hospital-in-the-Home (HITH) on IV antibiotics who then switch to oral antibiotics. In addition, the study will assess how feasible and acceptable it is to track children's symptoms via the Garmin Smartwatch and the WeGuide platform (WeGuide is a patient engagement software platform that allows for enrolment, consent, and data collection \[via questionnaires/surveys and from the Garmin Smartwatches\] through a singular platform).
Eligibility Criteria
Inclusion Criteria: * Between the ages of ≥ 4 years and ≤ 17 years at enrolment. * Diagnosed with any of the following at RCH ED: urinary tract infection (UTI), cellulitis, impetigo, pharyngitis, tonsillitis, respiratory tract infections, otitis media. * Prescribed oral antibiotics (either immediately or as switch from IV antibiotics after transfer to HITH) as standard of care due to having uncomplicated infection as deemed by their treating doctor. * Parent/guardian provides a signed and dated informed consent form. Exclusion Criteria: \- Parent/guardian does not speak English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07093749 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 17 Years, studying Urinary Tract Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07093749 currently recruiting?
Yes, NCT07093749 is actively recruiting participants. Contact the research team at penelope.bryant@rch.org.au for enrollment information.
Where is the NCT07093749 trial being conducted?
This trial is being conducted at Melbourne, Australia.
Who is sponsoring the NCT07093749 clinical trial?
NCT07093749 is sponsored by Murdoch Childrens Research Institute. The trial plans to enroll 300 participants.